Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> CARDIOVASCULAR DISEASE Latest News

JAN 23, 2013 - MedPage Today

A Must Read - Share

Omontys Safety Still a Problem for Nondialysis Patients (CME/CE)

(MedPage Today) -- The anemia drug peginesatide (Omontys) in chronic kidney disease patients not undergoing hemodialysis may carry an increased risk of cardiovascular events, two paired trials suggested.

Tags: Omontys Safety Still a Problem for Nondialysis Patients (CME/CE),  Cardiovascular Disease Latest News